Board Member
Quest Diagnostics Inc (DGX)Equibles does not estimate personal net worth.
Get an email with a short summary when Quest Diagnostics Inc publishes a filing, an earnings call transcript or a press release.
Get DGX alertsJames E. Davis is recorded as Board Member at Quest Diagnostics Inc (DGX) since January 1, 2022 and CEO at Quest Diagnostics Inc (DGX). The newest filing on record that lists James E. Davis as Board Member at Quest Diagnostics Inc (DGX) is dated April 6, 2026. Quest Diagnostics Inc reported in an 8-K filed November 1, 2022 that James E. Davis was appointed Chief Executive Officer and President, effective November 1, 2022. Quest Diagnostics Inc reported in an 8-K filed November 1, 2022 that James E. Davis was appointed director, effective November 1, 2022. The proxy statement of Quest Diagnostics Inc reports total compensation of $15,498,479 for James E. Davis in fiscal 2025, including a base salary of $1,250,000. Disclosed compensation is on record for 6 fiscal years. James E. Davis has spoken on 1 earnings call across 1 company, most recently for Quest Diagnostics Inc on October 22, 2026. Quest Diagnostics Inc is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Quest Diagnostics Inc includes Mr. Davis (CEO), Sam A. Samad (CFO), Michael E. Prevoznik (General Counsel) and 7 others.
“On November 1, 2022, the Company issued a press release announcing that Mr. Davis became Chief Executive Officer and President of the Company, and Stephen H. Rusckowski remains Chairman of the Company, in each case effective November 1, 2022.”
“On October 31, 2022, the Board of Directors (the "Board") of Quest Diagnostics Incorporated (the "Company") increased the Board's size from 9 to 10 directors and elected James E. Davis to fill the resulting vacancy effective November 1, 2022.”
“I'm excited to discuss our strong performance in the third quarter and how our strategy to connect people and providers to innovative testing and actionable insights is illuminating paths for better health and generating shareholder value.”
2022-01-01–present
Last confirmed April 6, 2026
Diagnostics & Research · Healthcare
CEO, Board Member
2022-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Quest Diagnostics Inc (DGX) | Chairman, Chief Executive Officer and President | $1,250,000 | $15,498,479 |
| 2024 | Quest Diagnostics Inc (DGX) | Chairman, Chief Executive Officer and President | $1,250,000 | $14,404,862 |
| 2023 | Quest Diagnostics Inc (DGX) | Chairman, Chief Executive Officer and President | $1,175,000 | $12,673,834 |
| 2022 | Quest Diagnostics Inc (DGX) | Chairman, Chief Executive Officer and President | $805,769 | $11,883,027 |
| 2021 | Quest Diagnostics Inc (DGX) | Chairman, Chief Executive Officer and President | $625,385 | $3,771,341 |
| 2020 | Quest Diagnostics Inc (DGX) | Chairman, Chief Executive Officer and President | $577,231 | $3,694,706 |
